PhRMA's SVP says newspaper overlooks benefit of DTC

Share this article:
PhRMA SVP Ken Johnson, responding to a Christian Science Monitor piece critical of drug DTC advertising, said the newspaper "unfortunately overlooks the educational benefits of direct-to-consumer advertising of prescription medicines."
Share this article:
You must be a registered member of MMM to post a comment.

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.